DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers.

已完结 10 由橘子发布于 2026/5/17 21:10:44

DOI:10.1016/j.annonc.2026.04.004
作者：S P Patel, M Othus, Y K Chae, T Azenkot, C Alviz, S Threlkel, C Haymaker, H Z Streicher, C M Magner, H X Chen, E Sharon, C W Ryan, C D Blank
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Background: We summarize final results of the NCI/SWOG S1609 trial, whose objective was to evaluate efficacy signals across 53 refractory rare cancer cohorts treated with dual CTLA-4 and PD-

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Investigation of the Alternations in the Muscle Quality of Swimming Crab (Ovalipes punctatus) during Cold-Chain Transportation Using Physicochemical and TMT-Based Quantitative Proteomic Analysis